The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2024
Filed:
Nov. 21, 2022
Applicant:
Rosalind Franklin University of Medicine & Science, North Chicago, IL (US);
Inventor:
Bruce L. Riser, Kenosha, WI (US);
Assignee:
Rosalind Franklin University of Medicine and Science, North Chicago, IL (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61K 35/12 (2015.01); A61K 35/28 (2015.01); A61K 35/51 (2015.01); A61K 38/04 (2006.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); C07K 14/475 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 9/0014 (2013.01); A61K 35/12 (2013.01); A61K 35/28 (2013.01); A61K 35/51 (2013.01); A61K 38/04 (2013.01); A61K 38/10 (2013.01); A61K 38/1709 (2013.01); C07K 14/4743 (2013.01); C07K 14/475 (2013.01);
Abstract
The present invention provides a method for treating a human patient with a pathology by administering to the subject an effective amount of an agent selected from the group of: native full-length CCN3 proteins; analog CCN3 full-length proteins with native cysteine residues substituted by a replacement amino acid; CCNp native peptide fragments having from about 12 to about 20 amino acids; analog CCNp peptide fragments with native cysteine residues substituted with a replacement amino acid; and combinations thereof.